MGTA Annual Accounts Payable
$2.45 M
-$586.00 K-19.28%
31 December 2022
Summary:
As of January 19, 2025, MGTA annual accounts payable is $2.45 million, with the most recent change of -$586.00 thousand (-19.28%) on December 31, 2022. During the last 3 years, it has fallen by -$358.00 thousand (-12.73%).MGTA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGTA Quarterly Accounts Payable
$813.00 K
-$267.00 K-24.72%
30 June 2023
Summary:
As of January 19, 2025, MGTA quarterly accounts payable is $813.00 thousand, with the most recent change of -$267.00 thousand (-24.72%) on June 30, 2023. Over the past year, it has dropped by -$1.23 million (-60.28%).MGTA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MGTA Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -19.3% | -60.3% |
| 3 y3 years | -12.7% | -69.3% |
| 5 y5 years | +1369.5% | -45.7% |
MGTA Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | ||||
| 5 y | 5-year | ||||
| alltime | all time | -34.7% | -83.4% |
Magenta Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| June 2023 | - | $813.00 K(-24.7%) |
| Mar 2023 | - | $1.08 M(-56.0%) |
| Dec 2022 | $2.45 M(-19.3%) | $2.45 M(-4.8%) |
| Sept 2022 | - | $2.58 M(+25.9%) |
| June 2022 | - | $2.05 M(-53.9%) |
| Mar 2022 | - | $4.44 M(+46.0%) |
| Dec 2021 | $3.04 M(-19.1%) | $3.04 M(+61.2%) |
| Sept 2021 | - | $1.89 M(-35.7%) |
| June 2021 | - | $2.93 M(+38.7%) |
| Mar 2021 | - | $2.11 M(-43.8%) |
| Dec 2020 | $3.76 M | $3.76 M(+57.4%) |
| Sept 2020 | - | $2.39 M(-9.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2020 | - | $2.65 M(-32.9%) |
| Mar 2020 | - | $3.95 M(+40.4%) |
| Dec 2019 | $2.81 M(-19.5%) | $2.81 M(+38.0%) |
| Sept 2019 | - | $2.04 M(-13.2%) |
| June 2019 | - | $2.35 M(-22.0%) |
| Mar 2019 | - | $3.01 M(-13.8%) |
| Dec 2018 | $3.49 M(+1991.0%) | $3.49 M(-28.7%) |
| Sept 2018 | - | $4.90 M(+227.1%) |
| June 2018 | - | $1.50 M(-13.5%) |
| Mar 2018 | - | $1.73 M(+936.5%) |
| Dec 2017 | $167.00 K(-90.0%) | $167.00 K |
| Dec 2016 | $1.67 M | - |
FAQ
- What is Magenta Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Magenta Therapeutics?
- What is Magenta Therapeutics annual accounts payable year-on-year change?
- What is Magenta Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Magenta Therapeutics?
- What is Magenta Therapeutics quarterly accounts payable year-on-year change?
What is Magenta Therapeutics annual accounts payable?
The current annual accounts payable of MGTA is $2.45 M
What is the all time high annual accounts payable for Magenta Therapeutics?
Magenta Therapeutics all-time high annual accounts payable is $3.76 M
What is Magenta Therapeutics annual accounts payable year-on-year change?
Over the past year, MGTA annual accounts payable has changed by -$586.00 K (-19.28%)
What is Magenta Therapeutics quarterly accounts payable?
The current quarterly accounts payable of MGTA is $813.00 K
What is the all time high quarterly accounts payable for Magenta Therapeutics?
Magenta Therapeutics all-time high quarterly accounts payable is $4.90 M
What is Magenta Therapeutics quarterly accounts payable year-on-year change?
Over the past year, MGTA quarterly accounts payable has changed by -$1.23 M (-60.28%)